Eczema study uncovers new immune pathway clues
NCT ID NCT04133506
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 17 times
Summary
This study looked at a specific immune pathway (PGE2/IL22/IL17) in people with eczema to understand how it contributes to the disease. Researchers measured levels of these immune signals in skin and blood samples from 38 participants, including those with eczema, psoriasis, and healthy volunteers. The goal was to identify which patients might benefit from future treatments targeting this pathway.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECZEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
QMRI
Edinburgh, United Kingdom
Conditions
Explore the condition pages connected to this study.